Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA)

Historical Holders from Q4 2022 to Q3 2025

Symbol
COYA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
16,681,212
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
4,755,804
Holdings value
$27,110,326
% of all portfolios
0%
Number of holders
35
Number of buys
17
Number of sells
-11
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DME Capital Management, LP 9.9% $10,783,903 1,651,440 DME Advisors GP, L.L.C. 31 Dec 2024
HIRSCHMAN ORIN 8% $8,710,491 1,333,919 Orin Hirschman 31 Dec 2024

Institutional Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 4,755,804 $27,110,326 +$1,543,439 $5.7 35
2025 Q2 4,484,686 $25,787,239 -$1,022,977 $5.75 33
2025 Q1 4,662,591 $30,167,676 +$1,480,613 $6.47 26
2024 Q4 4,444,580 $25,467,940 +$6,454,839 $5.73 26
2024 Q3 3,315,161 $21,385,210 +$304,078 $6.45 19
2024 Q2 3,268,292 $19,805,900 -$932,467 $6.06 19
2024 Q1 3,339,060 $33,123,748 +$5,311,359 $9.92 19
2023 Q4 2,822,037 $20,644,859 +$10,288,077 $7.41 20
2023 Q3 1,416,355 $5,449,280 +$229,488 $3.84 14
2023 Q2 1,351,642 $5,500,530 +$1,016,457 $4.07 13
2023 Q1 1,101,849 $4,368,596 +$41,079 $3.97 7
2022 Q4 1,091,417 $5,156,354 +$5,156,354 $4.74 4